Mithra Pharmaceuticals SA - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Mithra Pharmaceuticals SA are shownin the table. The analysis of Mithra Pharmaceuticals SA employs data points from across the web and also from available documents by Mithra Pharmaceuticals SA. Browse to the bottom of the page for potential risks for Mithra Pharmaceuticals SA based on industry, geography and marketcap.
Mithra Pharmaceuticals SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.4.
7.5
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
| 149 | Virbac SA | 7.6 | High |
| 160 | Mithra Pharmaceuticals SA | 7.5 | High |
| 160 | C4X Discovery Holdings PLC | 7.5 | High |
| 160 | Ascentage Pharma Group International | 7.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Mithra Pharmaceuticals SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose current and historical energy intensity?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA report the average age of the workforce?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose cybersecurity risks?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA offer flexible work?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA conduct supply chain audits?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Mithra Pharmaceuticals SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose water use targets?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA have careers partnerships with academic institutions?
Sign up for free to unlockDid Mithra Pharmaceuticals SA have a product recall in the last two years?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose incidents of discrimination?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Mithra Pharmaceuticals SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose parental leave metrics?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Mithra Pharmaceuticals SA involved in embryonic stem cell research?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose its waste policy?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA report according to TCFD requirements?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose energy use targets?
Sign up for free to unlockDoes Mithra Pharmaceuticals SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Mithra Pharmaceuticals SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Mithra Pharmaceuticals SA
These potential risks are based on the size, segment and geographies of the company.
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.